Literature DB >> 23225497

Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.

Kimberly A Aldinger1, Jillene Kogan, Virginia Kimonis, Bridget Fernandez, Denise Horn, Eva Klopocki, Brian Chung, Annick Toutain, Rosanna Weksberg, Kathleen J Millen, A James Barkovich, William B Dobyns.   

Abstract

The 22q13.3 deletion causes a neurodevelopmental syndrome, also known as Phelan-McDermid syndrome (MIM #606232), characterized by developmental delay and severe delay or absence of expressive speech. Two patients with hemizygous chromosome 22q13.3 telomeric deletion were referred to us when brain-imaging studies revealed cerebellar vermis hypoplasia (CBVH). To determine whether developmental abnormalities of the cerebellum are a consistent feature of the 22q13.3 deletion syndrome, we examined brain-imaging studies for 10 unrelated subjects with 22q13 terminal deletion. In seven cases where the availability of DNA and array technology allowed, we mapped deletion boundaries using comparative intensity analysis with single nucleotide polymorphism (SNP) microarrays. Approximate deletion boundaries for three additional cases were derived from clinical or published molecular data. We also examined brain-imaging studies for a patient with an intragenic SHANK3 mutation. We report the first brain-imaging data showing that some patients with 22q13 deletions have severe posterior CBVH, and one individual with a SHANK3 mutation has a normal cerebellum. This genotype-phenotype study suggests that the 22q13 deletion phenotype includes abnormal posterior fossa structures that are unlikely to be attributed to SHANK3 disruption. Other genes in the region, including PLXNB2 and MAPK8IP2, display brain expression patterns and mouse mutant phenotypes critical for proper cerebellar development. Future studies of these genes may elucidate their relationship to 22q13.3 deletion phenotypes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225497      PMCID: PMC3733662          DOI: 10.1002/ajmg.a.35700

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  35 in total

Review 1.  The developmental neurobiology of autism spectrum disorder.

Authors:  Emanuel DiCicco-Bloom; Catherine Lord; Lonnie Zwaigenbaum; Eric Courchesne; Stephen R Dager; Christoph Schmitz; Robert T Schultz; Jacqueline Crawley; Larry J Young
Journal:  J Neurosci       Date:  2006-06-28       Impact factor: 6.167

2.  Plexin-B2 controls the development of cerebellar granule cells.

Authors:  Roland H Friedel; Géraldine Kerjan; Helen Rayburn; Ulrich Schüller; Constantino Sotelo; Marc Tessier-Lavigne; Alain Chédotal
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

3.  Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.

Authors:  A Delahaye; A Toutain; A Aboura; C Dupont; A C Tabet; B Benzacken; J Elion; A Verloes; E Pipiras; S Drunat
Journal:  Eur J Med Genet       Date:  2009-05-18       Impact factor: 2.708

4.  The expression of plexins during mouse embryogenesis.

Authors:  Nina M Perälä; Tiina Immonen; Hannu Sariola
Journal:  Gene Expr Patterns       Date:  2005-02       Impact factor: 1.224

5.  22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.

Authors:  S U Dhar; D del Gaudio; J R German; S U Peters; Z Ou; P I Bader; J S Berg; M Blazo; C W Brown; B H Graham; T A Grebe; S Lalani; M Irons; S Sparagana; M Williams; J A Phillips; A L Beaudet; P Stankiewicz; A Patel; S W Cheung; T Sahoo
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

6.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

7.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

8.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.

Authors:  João Peça; Cátia Feliciano; Jonathan T Ting; Wenting Wang; Michael F Wells; Talaignair N Venkatraman; Christopher D Lascola; Zhanyan Fu; Guoping Feng
Journal:  Nature       Date:  2011-03-20       Impact factor: 49.962

9.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.

Authors:  Ozlem Bozdagi; Takeshi Sakurai; Danae Papapetrou; Xiaobin Wang; Dara L Dickstein; Nagahide Takahashi; Yuji Kajiwara; Mu Yang; Adam M Katz; Maria Luisa Scattoni; Mark J Harris; Roheeni Saxena; Jill L Silverman; Jacqueline N Crawley; Qiang Zhou; Patrick R Hof; Joseph D Buxbaum
Journal:  Mol Autism       Date:  2010-12-17       Impact factor: 7.509

10.  Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Silvana Beri; Cristina De Agostini; Francesca Novara; Marco Fichera; Lucia Grillo; Ornella Galesi; Annalisa Vetro; Roberto Ciccone; Maria Teresa Bonati; Sabrina Giglio; Renzo Guerrini; Sara Osimani; Susan Marelli; Claudio Zucca; Rita Grasso; Renato Borgatti; Elisa Mani; Cristina Motta; Massimo Molteni; Corrado Romano; Donatella Greco; Santina Reitano; Anna Baroncini; Elisabetta Lapi; Antonella Cecconi; Giulia Arrigo; Maria Grazia Patricelli; Chiara Pantaleoni; Stefano D'Arrigo; Daria Riva; Francesca Sciacca; Bernardo Dalla Bernardina; Leonardo Zoccante; Francesca Darra; Cristiano Termine; Emanuela Maserati; Stefania Bigoni; Emanuela Priolo; Armand Bottani; Stefania Gimelli; Frederique Bena; Alfredo Brusco; Eleonora di Gregorio; Irene Bagnasco; Ursula Giussani; Lucio Nitsch; Pierluigi Politi; Maria Luisa Martinez-Frias; Maria Luisa Martínez-Fernández; Nieves Martínez Guardia; Anna Bremer; Britt-Marie Anderlid; Orsetta Zuffardi
Journal:  PLoS Genet       Date:  2011-07-14       Impact factor: 5.917

View more
  28 in total

1.  SHANK Mutations May Disorder Brain Development.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02

Review 2.  Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Authors:  Jesse L Costales; Alexander Kolevzon
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 3.  Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms.

Authors:  Ece D Gamsiz; Laura N Sciarra; Abbie M Maguire; Matthew F Pescosolido; Laura I van Dyck; Eric M Morrow
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 4.  Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.

Authors:  Hala Harony-Nicolas; Silvia De Rubeis; Alexander Kolevzon; Joseph D Buxbaum
Journal:  J Child Neurol       Date:  2015-09-08       Impact factor: 1.987

5.  Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.

Authors:  Sara M Sarasua; Luigi Boccuto; Julia L Sharp; Alka Dwivedi; Chin-Fu Chen; Jonathan D Rollins; R Curtis Rogers; Katy Phelan; Barbara R DuPont
Journal:  Hum Genet       Date:  2014-01-31       Impact factor: 4.132

Review 6.  Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex.

Authors:  Maria Sundberg; Mustafa Sahin
Journal:  J Child Neurol       Date:  2015-08-24       Impact factor: 1.987

7.  Shank3-deficient rats exhibit degraded cortical responses to sound.

Authors:  Crystal T Engineer; Kimiya C Rahebi; Michael S Borland; Elizabeth P Buell; Kwok W Im; Linda G Wilson; Pryanka Sharma; Sven Vanneste; Hala Harony-Nicolas; Joseph D Buxbaum; Michael P Kilgard
Journal:  Autism Res       Date:  2017-10-20       Impact factor: 5.216

8.  Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid Syndrome.

Authors:  Siddharth Srivastava; Benoit Scherrer; Anna K Prohl; Rajna Filip-Dhima; Kush Kapur; Alexander Kolevzon; Joseph D Buxbaum; Elizabeth Berry-Kravis; Latha Soorya; Audrey Thurm; Craig M Powell; Jonathan A Bernstein; Simon K Warfield; Mustafa Sahin
Journal:  Pediatr Neurol       Date:  2018-09-21       Impact factor: 4.210

Review 9.  Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.

Authors:  Arianna Ricciardello; Pasquale Tomaiuolo; Antonio M Persico
Journal:  Am J Med Genet A       Date:  2021-05-05       Impact factor: 2.802

10.  An Autism-Associated Neuroligin-3 Mutation Affects Developmental Synapse Elimination in the Cerebellum.

Authors:  Esther Suk King Lai; Hisako Nakayama; Taisuke Miyazaki; Takanobu Nakazawa; Katsuhiko Tabuchi; Kouichi Hashimoto; Masahiko Watanabe; Masanobu Kano
Journal:  Front Neural Circuits       Date:  2021-06-28       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.